𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The construction of a firm's governance structure in a setting of uncertainty

✍ Scribed by Erik J. O'Donoghue


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
132 KB
Volume
25
Category
Article
ISSN
0143-6570

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Why does the firm look the way it does? Why does it have the structures it has? In particular, what is the function of the board of directors? Many papers have tried, and failed, to link the board's structure to the performance of the firm. Might the board have an alternative rationale for existence? In this paper, I explore the possibility of the board being used as a signaling device. The management, having information about the state of the world the investor does not, constructs a signal (the board of directors) to promote efficiency in an uncertain world. The construction of the board signals the state of the world to the investor, reducing the uncertainty, and thereby attracting necessary capital to the firm. I then examine the size of the signal with respect to other key firm characteristics. I find that the size of the signal diminishes as investors become more concentrated. Copyright Β© 2004 John Wiley & Sons, Ltd.


πŸ“œ SIMILAR VOLUMES


Corporate political strategies and firm
✍ Amy J. Hillman; Asghar Zardkoohi; Leonard Bierman πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 93 KB πŸ‘ 3 views

Firms employ a variety of political strategies (e.g., lobbying, contributions) in an attempt to gain influence or access to the public policy process. A variety of benefits may accrue to firms that are successful in creating a linkage with the government: information, access, influence, reduced unce

Governance in a period of strategic chan
✍ Thomas P. Weil πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 117 KB πŸ‘ 1 views

## Abstract The increased enrollment in managed care plans, merger mania and the development of politically and financially powerful integrated delivery systems have significantly complicated the governance of U.S. healthcare organizations. These modifications in fiscal incentives and the corporate